4 employees
Bsense Bio Therapeutics develops small molecules for the treatment of sensory hyperexcitability related disorders.
2018
$405K
from 2 investors over 2 rounds
Bsense Bio Therapeutics Ltd raised $405K on October 1, 2018
Investors: Takeda UK Limited and OrbiMed Advisors